231 related articles for article (PubMed ID: 23019074)
1. T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.
Rosenthal DW; DeVoti JA; Steinberg BM; Abramson AL; Bonagura VR
Mol Med; 2012 Dec; 18(1):1338-45. PubMed ID: 23019074
[TBL] [Abstract][Full Text] [Related]
2. Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor.
Lucs AV; Wu R; Mullooly V; Abramson AL; Steinberg BM
Mol Med; 2012 Mar; 18(1):244-9. PubMed ID: 22113496
[TBL] [Abstract][Full Text] [Related]
3. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
4. Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).
Israr M; DeVoti JA; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Front Immunol; 2020; 11():336. PubMed ID: 32210959
[TBL] [Abstract][Full Text] [Related]
5. Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.
DeVoti J; Hatam L; Lucs A; Afzal A; Abramson A; Steinberg B; Bonagura V
Mol Med; 2014 Aug; 20(1):372-80. PubMed ID: 24950037
[TBL] [Abstract][Full Text] [Related]
6. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
7. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
8. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
[TBL] [Abstract][Full Text] [Related]
9. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
10. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
11. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
[TBL] [Abstract][Full Text] [Related]
12. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Pakkanen PP; Aaltonen LM; Sorsa TA; Tervahartiala TI; Hagström JK; Ilmarinen TT
Head Neck; 2019 Feb; 41(2):309-314. PubMed ID: 30549356
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
Benedict PA; Ruiz R; Yoo M; Verma A; Ahmed OH; Wang B; Dion GR; Voigt A; Merati A; Rosen CA; Amin MR; Branski RC
Laryngoscope; 2018 Jan; 128(1):138-143. PubMed ID: 28714564
[TBL] [Abstract][Full Text] [Related]
14. Juvenile recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: Initial report.
Rojas-Lechuga MJ; Remacha J; González-Sánchez N; Grau JJ; Castillo P; Haag O; Vilaseca I
Int J Pediatr Otorhinolaryngol; 2020 Oct; 137():110194. PubMed ID: 32658799
[TBL] [Abstract][Full Text] [Related]
15. Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.
DeVoti JA; Rosenthal DW; Wu R; Abramson AL; Steinberg BM; Bonagura VR
Mol Med; 2008; 14(9-10):608-17. PubMed ID: 18607510
[TBL] [Abstract][Full Text] [Related]
16. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Bentley PL; Coulter MJ; Nelson BL
Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
[TBL] [Abstract][Full Text] [Related]
18. Recurrent respiratory papillomatosis: A state-of-the-art review.
Fortes HR; von Ranke FM; Escuissato DL; Araujo Neto CA; Zanetti G; Hochhegger B; Souza CA; Marchiori E
Respir Med; 2017 May; 126():116-121. PubMed ID: 28427542
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
Pawlita M; Gissmann L
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
